We’re the global leader in LNP
technology.
Acuitas collaborates with our partners to advance human health.
Acuitas: (noun) insight, perception and sharpness.
Founded by Drs. Thomas Madden, Michael Hope and Pieter Cullis in 2009, Acuitas Therapeutics is a Vancouver-based biotechnology company with a global reputation for innovation and excellence. We are strategically focused on working with our partners to advance nucleic acid therapeutics enabled by our best-in-class lipid nanoparticle (LNP) delivery platform.
Our partner-centric business model prioritizes impact, opening doors to limitless applications across a broad spectrum of nucleic acid-based medicines enabled by our LNP delivery technology. Through our in-house R&D and our work with partners, we operate at the leading edge of scientific innovation and discovery. We’re inspired by science’s transformative power and its role in helping people live healthier lives.
The Story of Acuitas
Learn more about our journey to become the global leader in LNP delivery technology.
Acuitas is a purpose-driven company on a mission to make the world a healthier place.
Our Vision
We are delivering a future where human health benefits from the full potential of nucleic acid therapeutics enabled by LNP delivery.
Nucleic acid therapeutics have the potential to tackle illnesses for which there is currently no treatment or cure. We are helping to fulfill this potential by solving the challenge of delivering these fragile medicines to the body.
Our Why
Acuitas’ unifying goal is to improve human health through new therapeutics.
Our award-winning team consistently raises the bar in the biotech industry.
The Acuitas team is made up of some of the world’s most experienced and talented scientists and business professionals.
2024
Association of Fundraising Professionals – Greater Vancouver Chapter’s Giving Hearts Award: Outstanding Corporation
2022
Governor General’s Innovation Award – Drs. Thomas Madden, Michael Hope and Pieter Cullis
2022
An EY Entrepreneur of the Year Canada Winner – Dr. Thomas Madden
2022
Greater Vancouver Board of Trade’s Business Distinction Award for Business Growth over $5M in Revenue
2022
BIOTECanada’s Game Changing Leadership Award – Dr. Thomas Madden
2022
Life Sciences BC’s Life Sciences Company of the Year
2021
Life Sciences BC’s Global Impact Award
Acuitas’ success is driven by our experienced and remarkable team.
The expertise of the Acuitas team is unparalleled in LNP delivery technology. We are focused on working with our partners to accelerate their path to the clinic and the market.
Along with our world-leading expertise in LNP research and development, the Acuitas team has broad and deep knowledge of the drug development process, including regulatory approval submissions, manufacturing and commercialization.
Explore a career at Acuitas.
Some of the most brilliant and talented individuals in the life sciences sector work here. Together, we are dedicated to improving human health and positively impacting the lives of people around the world. Check out what it’s like to work at Acuitas, a biotech firm at the forefront of lifesaving, innovative and best-in-class science.